As we discussed yesterday, the math behind “asymmetric” investing is compelling… Perhaps the sector that’s most illustrative of its effectiveness is biotechnology. Let’s consider a hypothetical portfolio comprised of three well-known Big Pharma stocks: Pfizer (NYSE: PFE), Merck (NYSE: MRK), and Abbott Laboratories (NYSE: ABT). Scrutinizing their fundamentals (balance… Read More

The following is an interview with Dr. Joe Duarte, a medical doctor and veteran investor with decades of experience following medical technology innovation. We sat down to discuss the virtual and augmented reality sector, where Dr. Joe and the team at Breakthrough Tech Profits recently made a trio of investment… Read More

Oil prices are plunging and yet solar power continues to thrive. We explain the dynamics behind solar’s inexorable rise Read More

The carmaker's credibility has been badly damaged. Read More

As the Federal Reserve mulls an interest rate hike, this boutique bank is ready for anything. Read More

This old-fashioned conglomerate is still racking up impressive returns. Read More

The search giant has remade itself into a conglomerate. Will the move trigger its next growth spurt? Read More

Soaring profits, rising dividend make our #1 tech pick a strong choice for any investor’s portfolio. Read More

This little-known tech company keeps racking up gains. Read More

This restaurant chain has found ways to separate itself from the pack. Read More